Winshine Science Company Limited (HKEX: 209) Releases 2025 Annual Report: Key Highlights and Risks for Investors

Financial Performance and Position

• Revenue Decline: The Group reported a significant decrease in annual revenue to HK\$382.4 million in 2025, down from HK\$515.9 million in 2024. This represents a 25.8% year-on-year drop, largely attributable to the challenging business environment, heightened competition, and industry-specific headwinds.
• Substantial Losses: Loss attributable to owners widened to HK\$92.8 million in 2025 (2024: HK\$73.0 million). The Group has reported losses for multiple consecutive years, raising concerns about its profitability trend.
• Net Liabilities and Capital Deficiency: As of 31 December 2025, the Group’s net liabilities stood at HK\$219.9 million, up from HK\$140.5 million a year earlier. Capital deficiencies attributable to shareholders increased by 56.6% to HK\$217.7 million.
• Net Current Liabilities: The Group’s net current liabilities reached HK\$296.7 million, worsening from HK\$220.3 million in 2024.
• Gearing Ratio: The Group’s gearing ratio, indicating high financial leverage, soared to 188.4% (2024: 156.9%), highlighting increased dependency on debt financing. Total borrowings rose to HK\$257.2 million (2024: HK\$217.1 million).
• Liquidity Concerns: The current ratio deteriorated to 0.45x (2024: 0.54x), signaling potential challenges in meeting short-term obligations despite raising fresh capital.

Fundraising Activities and Dilution Risk

• Multiple Equity Fundraisings in 2025:
  • January 2025: Subscription of new shares under general mandate raised HK\$1.2 million, fully utilized for professional fees and operational expenses.
  • September 2025: Placing of new shares under general mandate raised HK\$10.4 million, with approximately 50% used for loan repayment and the remainder for working capital and corporate expenses.
  • October 2025 – January 2026: Major Rights Issue: The Company undertook a large-scale rights issue, issuing 1,299,962,832 new shares at HK\$0.14 per share, raising net proceeds of HK\$176.7 million. About 66% was earmarked for debt repayment and the balance for working capital and operational needs.
• Shareholder Dilution: These fundraising activities have significantly increased the number of shares in issue, resulting in dilution for existing shareholders.
• Ongoing Reliance on Capital Markets: The Company’s repeated capital raising indicates ongoing liquidity constraints and dependence on external funding.

Going Concern and Auditor’s Emphasis

• Material Uncertainty on Going Concern: Both management and the independent auditor have highlighted “material uncertainties” regarding the Group’s ability to continue as a going concern. The Group’s significant net losses, negative net assets, and heavy short-term debt burden raise material doubts about survival without successful fundraising and cost control measures.
• Auditor’s View: The auditor has not modified its opinion but stresses that the Group’s ability to continue as a going concern depends on the successful implementation of fundraising plans and improvement in liquidity.

Operational Risks and Business Concentration

• Customer Concentration Risk: The Group’s five largest customers accounted for 93.3% of total revenue, with the largest single customer contributing 71.5%. This high dependency poses a considerable risk if any key customer reduces orders or terminates business.
• Supplier Concentration: The five largest suppliers accounted for 37.5% of total purchases, with the largest at 12%.
• Industry Competition and Market Risks:
  • The toy industry is highly competitive, with low barriers to entry and increasing threats from electronic gaming products.
  • The Group is vulnerable to shifts in consumer preference, rising production and labor costs, and supply chain disruptions.
  • Export focus on the US market exposes the Group to tariff risks and geopolitical tensions, especially given the ongoing global trade conflicts.
• Regulatory Compliance: No material breaches or non-compliance events were reported during the year. The Group continues to monitor and adapt to evolving regulatory requirements in key export markets and in the PRC.

Corporate Governance and Board Changes

• Board Composition and Compliance: In 2025, the Company temporarily failed to comply with Listing Rules regarding the number and qualifications of independent non-executive directors due to retirements and resignations. Compliance was restored with new appointments in August 2025.
• Share Option Scheme: A new share option scheme was adopted in October 2024, but no options were outstanding as of year-end 2025.
• No Final Dividend: The Board has not recommended any dividend for 2025 (as in 2024), reflecting the Group’s continued losses and capital deficiency.
• Major Shareholders: As of 31 December 2025, two shareholders held more than 5% each of the Company’s shares, with the largest (Peak Access, controlled by Ms. Wang) holding 20.14%.

Key Takeaways and Share Price Implications

• Chronic Losses and Worsening Capital Deficiency: The ongoing losses and deepening negative equity are serious red flags for investors. The Company’s survival relies on further capital injections and successful execution of strategic turnaround plans.
• Massive Rights Issue and Dilution: The recent rights issue has significantly diluted existing shareholders, and future fundraisings cannot be ruled out given the Group’s cash flow position.
• Going Concern Warning: The explicit going concern warning from both management and auditors is a critical risk factor that could materially affect investor sentiment and share price.
• Operational and Concentration Risks: The Group’s high customer dependency and exposure to global trade risks make it particularly vulnerable to external shocks.
• No Dividend Outlook: With no distributable reserves or dividend payments, the stock may not appeal to income-focused investors.

Conclusion

Winshine Science Company Limited faces major financial and operational challenges, with mounting losses, heavy debt, ongoing dilution, and material going concern uncertainties. Investors should closely monitor the Company’s cash flow developments, fundraising activities, and the outcome of its strategic initiatives. The significant risks highlighted in the 2025 annual report could have a material impact on the Company’s share price and should be considered carefully before making investment decisions.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with professional advisors before making investment decisions. Past performance is not indicative of future results. The writer and publisher accept no liability for any losses arising from reliance on this information.

View WINSHINE SCI Historical chart here